The Hidden Mystery Behind Local Anesthesia Drugs Market

Medical facilities perform various surgeries in the areas of orthopedics, trauma, ophthalmology, cardiovascular, respiratory, oncology, neurology, endoscopy, laparoscopy, and cosmetics. These surgeries help to treat cardiovascular diseases, gastrointestinal diseases, urological disorders, spinal abnormalities, brain tumors, and orthopedic deformities.

Every surgical procedure can be painful; therefore, anesthesia is administered during surgical procedures to keep individuals pain-free and unconscious during the procedure. The majority of individuals in the age group of 60 years and above are susceptible to age-related conditions such as COPD, arthritis, and heart disorders, and may require surgical procedures for disease management. Anesthesia is essential to sedate patients to administer during treatment.

The rise in surgical procedures has increased the demand for anesthesia drugs in hospitals, clinics, and ASCs. For instance, more than 1 million joint replacement surgeries will be performed every year in the United States, with which about 720,000 knee replacements and 330,000 hip replacements. For major surgery, such as hip or knee replacement, local anesthesia may be used to complement the main type of anesthesia that is used.

According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with cardiology, surgical, and obstetrical procedures being the most common ones.

In addition, growing cosmetic surgeries across the world especially in the United States will drive the market further since local anesthetics were used in around 89% of all cosmetic procedures on the head and neck.

According to the American Society of Plastic Surgeons (ASPS) study, more than 17.7 million surgical and minimally invasive cosmetic procedures were performed in the United States in 2018.

In Europe, a greater number of surgeries are being performed for cases of cataracts, tonsillectomy, colonoscopy, caesarean sections, and hip replacements. In addition, several procedures, such as cochlear implantation, laparoscopic colectomy, laparoscopic hysterectomy, secondary hip replacement, and knee replacement, have become more frequent in recent years.

Moreover, the increasing number of cataract surgeries in the world is also one of the prime drivers of the market since the majority of cataract patients are operated on under local anesthesia. In the United States, nearly 3 million cataract surgeries will be performed every year. Cataracts are common among older people. Half of all Americans develop one by the time they're 80 years old.

Similarly, in 2017, around 5 million cataract surgeries are performed in the EU Member States. Latvia has the highest rate of cataract surgeries in Europe at 1,656 cases per 100,000, followed by Estonia with a rate of 1391.5. By contrast, cataract surgery was performed fewer than 400 times per 100 000 inhabitants in Romania, Cyprus, and Ireland.

Hence, the overall increase in the number of surgeries performed has a strong impact on the anesthetic drug market, as these drugs are used in all surgical procedures to reduce pain during surgery.

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com